Rauch M, Loosfelt H, Philibert D, Milgrom E
Eur J Biochem. 1985 Apr 15;148(2):213-8. doi: 10.1111/j.1432-1033.1985.tb08827.x.
RU486 is a recently described antiprogesterone. In order to be able to understand its mechanism of action it is necessary to analyze its effect on a discrete gene product. We show here that the induction of uteroglobin mRNA by progesterone in the rabbit endometrium may be a suitable model for such studies since RU486 totally inhibits this effect without itself exerting any agonistic activity. Moreover, RU486, which does not bind to the estrogen receptor and is devoid of general antiestrogenic activity, partially inhibits the induction by estradiol of uteroglobin mRNA. Studies of the interaction between [3H]RU486 and the progesterone receptor have been undertaken with the aim of understanding the antagonistic effect of this compound. The binding to DNA-cellulose of heat-activated [3H]RU486-receptor complexes was slightly decreased (37%) when compared with that of the agonist [3H]R5020-receptor complexes (47%). Detailed analysis of this difference showed that it was due to both a decreased activation of complexes and to a diminished affinity of activated complexes towards DNA. The change in activation was shown by the fact that at high concentrations of DNA, where all activated complexes are bound, agonist-receptor complexes were bound to DNA in higher proportion than antagonist-receptor complexes. Moreover a difference was also observed when studying the binding of agonist-receptor and antagonist-receptor complexes to charged resins (phosphocellulose, DEAE-cellulose) which are known to discriminate between activated and non-activated complexes. Decreased affinity to DNA of antagonist-receptor complexes was shown by studying their binding at various concentrations of DNA, either in crude cytosol or after isolating a homogenous population of activated-receptor complexes by DNA-cellulose chromatography and by comparing the salt extraction from DNA-cellulose of agonist-receptor and antagonist-receptor complexes. Both effects (decreased activation and diminished affinity towards DNA) were relatively moderate and could account only for a small decrease in the agonistic activity of RU486. Thus, the fact that this compound is a complete antagonist without any agonistic activity can only be explained by a defect in some further step of hormone action as, for instance in the specific interaction with the regulatory regions of the uteroglobin gene. No immunological difference could be detected between [3H]R5020-receptor and [3H]RU486-receptor complexes, both interacted with the five monoclonal antibodies raised against purified R5020-receptor complexes.(ABSTRACT TRUNCATED AT 400 WORDS)
RU486是一种最近被描述的抗孕激素。为了能够理解其作用机制,有必要分析其对一种特定基因产物的影响。我们在此表明,孕酮对兔子宫内膜中子宫珠蛋白mRNA的诱导作用可能是此类研究的一个合适模型,因为RU486完全抑制了这种作用,而自身不发挥任何激动活性。此外,RU486不与雌激素受体结合且无一般抗雌激素活性,它部分抑制了雌二醇对子宫珠蛋白mRNA的诱导作用。为了理解该化合物的拮抗作用,已对[3H]RU486与孕酮受体之间的相互作用进行了研究。与激动剂[3H]R5020 - 受体复合物(47%)相比,热激活的[3H]RU486 - 受体复合物与DNA - 纤维素的结合略有下降(37%)。对这种差异的详细分析表明,这是由于复合物的激活减少以及激活后的复合物对DNA的亲和力降低所致。激活的变化体现在以下事实上:在高浓度DNA(此时所有激活的复合物都已结合)的情况下,激动剂 - 受体复合物与DNA结合的比例高于拮抗剂 - 受体复合物。此外,在研究激动剂 - 受体和拮抗剂 - 受体复合物与已知能区分激活和未激活复合物的带电树脂(磷酸纤维素、二乙氨基乙基纤维素)的结合时,也观察到了差异。通过研究拮抗剂 - 受体复合物在不同浓度DNA下的结合情况,无论是在粗制胞质溶胶中,还是在通过DNA - 纤维素色谱法分离出均匀的激活受体复合物群体后,并比较从DNA - 纤维素中提取激动剂 - 受体和拮抗剂 - 受体复合物的盐析情况,表明拮抗剂 - 受体复合物对DNA的亲和力降低。这两种效应(激活减少和对DNA的亲和力降低)都相对较小,仅能解释RU486激动活性的小幅下降。因此,该化合物是一种完全拮抗剂且无任何激动活性这一事实,只能通过激素作用的某些进一步步骤中的缺陷来解释,例如在与子宫珠蛋白基因调控区域的特异性相互作用中。在[3H]R5020 - 受体和[3H]RU486 - 受体复合物之间未检测到免疫差异,二者都能与针对纯化的R5020 - 受体复合物产生的五种单克隆抗体相互作用。(摘要截取自400字)